Pongan E, Rouch I, Vernaudon J, Bachelet R, Novais T, Coste MH, Edjolo A, Garnier-Crussard A.
Arch Clin Neuropsychol. 2025 Jan 20:acaf001. doi: 10.1093/arclin/acaf001. Online ahead of print.
PMID: 39829263
Abstract
Background: End-stage chronic kidney disease (CKD) is a significant concern for older adults and is often associated with cognitive impairment (CI). The origin of this CI is multifactorial, involving vascular and metabolic factors. Additionally, renal treatments, including dialysis, may affect cognition. This study aimed to assess the neuropsychological profiles of these patients and understand the effects of dialysis treatment.
Methods: We conducted an observational retrospective study including older adults with end-stage CKD attending for kidney transplantation (KT). Comprehensive neuropsychological assessments were conducted. Composite cognitive scores were computed. Multivariate regression models were used to assess associations between cognition and dialysis status.
Results: We included 223 patients (151 treated with dialysis, 72 with conservative management), mean age of 73.5 ± 3.4. We observed a high prevalence of CI, around 30% for global cognition and affecting all neuropsychological domains. Patients treated with dialysis exhibited lower cognitive performance compared to those not undergoing dialysis, particularly in episodic (p = .031) and working memory (p = .024).
Conclusion: This study confirms the high prevalence of CI in end-stage CKD, with dialysis being associated with worse episodic and working memory compared to non-dialyzed participants. Future investigations are needed to track the long-term cognitive trajectory of patients on the KT waiting list and post-transplantation.
Trial registration: Retrospectively registered, no 22-808 on July 7th, 2022, CNIL register number 22-5808.
Keywords: End-stage chronic kidney disease; cognitive impairment; dialysis; geronto-nephrology; nephrogeriatrics; neuropsychology; older adults.
